reimbursement

2024 Trends: A Comprehensive Look at the Twists and Turns in Biopharma Dealmaking The biopharmaceutical industry is constantly evolving, driven...

The field of neuroscience diagnostics and therapeutics has experienced significant growth in recent years, with the market size exceeding $600...

Cell and gene therapy have emerged as promising fields in the healthcare industry, offering potential cures for previously untreatable diseases....

An Overview of Cell-Free DNA Market Trends: Detecting Cancer Early Cancer is a leading cause of death worldwide, and early...

Starting a medical device startup can be an exciting and rewarding venture. However, it is crucial to navigate the complex...

Prominent Cardiovascular Societies’ Experts Encourage Wider Use of IVUS in Peripheral Interventions to Enhance Patient Care, Reports Medical Device News...

Alnylam Pharmaceuticals, a leading biopharmaceutical company focused on RNA interference (RNAi) therapeutics, recently released its preliminary financial results for the...

Understanding the Process of Selling Your Body for Research at QPS Missouri Medical research plays a crucial role in advancing...

Sequana Medical, a Swiss medical device company, has recently announced that it has received Current Procedural Terminology (CPT®) III reimbursement...

The biotech industry is known for its volatility and the potential for significant stock price movements based on various events....

Pulnovo Medical, a leading medical device company, has recently achieved significant milestones with its Peripheral Arterial Disease Neurostimulation (PADN) device....

GM Files Lawsuit Against San Francisco Seeking Reimbursement of Over $108 Million in Cruise Taxes General Motors (GM), one of...

As the biopharmaceutical industry continues to evolve and innovate, it is important to stay informed about the latest trends and...